Doctor Details

About Doctor

Dr Umesh T is an Elite Neurologist in Hyderabad with extensive expertise in all aspects of neurology. He has more than 25 years of comprehensive experience in neurology. Prior to joining TX Hospitals, he worked as Consultant Neurologist at Wokhardt’s Kamineni Hospital; Consultant Neurologist at Mediciti Hospitals; Visiting Consultant Neurologist at Princess Durushewar Children’s and General Hospital; Consultant Neurologist at Owaisi Hospital and Research Centre and Consultant Neurologist at Yashoda Hospital.

Dr Umesh obtained postgraduate MD degree from Karnataka University. After completing a post-doctoral DM training in Neurology, he pursued and successfully completed DNB Neurology from All India Institute of Medical Sciences, New Delhi. Later he worked as a research fellow and published papers from the Neurology Department of Bombay Hospital.

Subsequently, he moved to South India and pioneered the establishment of a neurology department at a leading corporate hospital in Hyderabad. He has been a great professor for Neurology residents and also been a Professor for MRCP residents.

Dr Umesh is one among a very few neuro physicians in Hyderabad who possesses hands-on expertise in dealing with acute stroke, epilepsy and neuro-oncological and neurodegenerative diseases.

Dr Umesh has profound expertise in handling intricate neurological issues and even the rarest ones. He deals with such issues with utmost care, compassion and composure. His diligent approach in managing intricate neurological problems astuteness in diagnosing complex neurological conditions such as rare amyotrophic lateral sclerosis (ALS), Duchenne muscular dystrophy, and Huntington’s disease, multiple sclerosis, Guillain-Barre syndrome, Bell’s palsy, Parkinson’s and Alzheimer’s disease make him the best neurologist in Hyderabad.

Dr Umesh T treats the following neurological conditions: headache, migraines, tension headaches, cluster headaches, muscle weakness, movement disorders, balancing and coordination problems, neurological back pain, ankylosing spondylitis, neck pain, cervical spondylosis, spinal pain, brain haemorrhage, brain stroke, Transient ischemic attack (TIA), sleep disorders, fatigue, hematoma, epilepsy, walking difficulty, weakness in hands and legs, peripheral neuropathy, memory loss, speech difficulty, apraxia of speech, encephalopathy, dementia, personality changes, concentration issues and other degenerative diseases of the nervous system.

Memberships, Awards and Accomplishments

Dr Umesh is a member of several associations including Indian Epilepsy Society and Neurology Society of India. He secured first rank in DM – Neurology Residency programme, Bombay University, Bombay, India. In 1997, he was awarded the best outgoing Young Neurologist from Mumbai university. Dr Umesh is highly intellectual, deep sighted, research-oriented neurologist with immense interest in research activities as he worked as a principal investigator for several research and scientific studies.

His original research work pertaining to long-term outcome in Myasthenia Gravis patients awarded him the finest clinician among his peers. He presented many papers in National Neuroscientist Meet. Dr Umesh heads many clinical trials as principal investigator and conducted and organised regional neurology meets.

  • MBBS, Dr. B.R. Ambedkar Medical College, Bengaluru, Karnataka
  • MD (General Medicine), M R Medical College, Gulbarga, Karnataka
  • DM (Neurology), B.Y.L. Nair Charitable Hospital, Mumbai, Maharashtra
  • PROFESS Study: 2004-2006
  • Principle investigator: PROFESS Study a large multicentre, double-blind placebo-controlled study – “Preventing Regimen for Effectively Avoiding Secondary Stroke” organized by Boehringer Ingelheim Group, France.
  • REGENESIS- LED Study: 2010-2011 – organized by Stem cell Therapeutics, Calgary, Canada)
  • Principal Investigator: Phase IIb prospective, randomized, double blind, placebo-controlled, multicentre, dose escalation study of NTx-265 Human Chorionic Gonadotrophin (HCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients.
  • Conversion Study to determine the Relative Bioavailability of Topiramate MR vs Topirmate IR in subjects with Partial onset Epilepsy (Supernus Pharmaceutical Inc, Rockville MD20850 US)
Clinical Audits and Publications
  • Familial Pallidal degeneration with heterogeneous phenotypic presentation Neurology, India 1997
  • Case study of series of Moya disease in Mumbai update 1998.
  • Myasthenia Gravis: A study from India, Neurology India 2008. J Neurology Neurosurgery, Psychiatry 1998;65;492-6.
  • Vitamin B12 deficiency causing neurological syndrome with rare skin manifestation; International Journal of Current Advanced Research, March 2016
  • Unusual case of stroke in young; J Med Allied Sci 2017